Leukemic Dendritic Cell Vaccination in Patients With Acute Myeloid Leukemia

Clinical trial NCT01373515 · COMPLETED

Trial details

NCT number: NCT01373515
Sponsor: Mendus
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia (AML)Leukemic Dendritic Cell Vaccination

Start date: 2011-04-01
Primary completion: 2013-02-01
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.